Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age.
This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia Drugs. This report contains market size and forecasts of Acute Myeloid Leukemia Drugs in global, including the following market information:
Global Acute Myeloid Leukemia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Acute Myeloid Leukemia Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Acute Myeloid Leukemia Drugs companies in 2022 (%)
The global Acute Myeloid Leukemia Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
DC regimen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Myeloid Leukemia Drugs include Ambit Biosciences Corporation, Celgene Corporation, Cephalon, Clavis Pharma, Eisai, Genzyme Corporation and Sunesis Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Myeloid Leukemia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Myeloid Leukemia Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Myeloid Leukemia Drugs Market Segment Percentages, by Type, 2022 (%)
DC regimen
AVD Regimen
VCD regimen
Global Acute Myeloid Leukemia Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Myeloid Leukemia Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Acute Myeloid Leukemia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Myeloid Leukemia Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Myeloid Leukemia Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Acute Myeloid Leukemia Drugs revenues share in global market, 2022 (%)
Key companies Acute Myeloid Leukemia Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Acute Myeloid Leukemia Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ambit Biosciences Corporation
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Myeloid Leukemia Drugs, market overview.
Chapter 2: Global Acute Myeloid Leukemia Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Acute Myeloid Leukemia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Myeloid Leukemia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Acute Myeloid Leukemia Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Myeloid Leukemia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Myeloid Leukemia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Myeloid Leukemia Drugs Overall Market Size
2.1 Global Acute Myeloid Leukemia Drugs Market Size: 2022 VS 2029
2.2 Global Acute Myeloid Leukemia Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Acute Myeloid Leukemia Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Acute Myeloid Leukemia Drugs Players in Global Market
3.2 Top Global Acute Myeloid Leukemia Drugs Companies Ranked by Revenue
3.3 Global Acute Myeloid Leukemia Drugs Revenue by Companies
3.4 Global Acute Myeloid Leukemia Drugs Sales by Companies
3.5 Global Acute Myeloid Leukemia Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Acute Myeloid Leukemia Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Acute Myeloid Leukemia Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Drugs Players in Global Market
3.8.1 List of Global Tier 1 Acute Myeloid Leukemia Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Myeloid Leukemia Drugs Market Size Markets, 2022 & 2029
4.1.2 DC regimen
4.1.3 AVD Regimen
4.1.4 VCD regimen
4.2 By Type - Global Acute Myeloid Leukemia Drugs Revenue & Forecasts
4.2.1 By Type - Global Acute Myeloid Leukemia Drugs Revenue, 2018-2023
4.2.2 By Type - Global Acute Myeloid Leukemia Drugs Revenue, 2024-2029
4.2.3 By Type - Global Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Acute Myeloid Leukemia Drugs Sales & Forecasts
4.3.1 By Type - Global Acute Myeloid Leukemia Drugs Sales, 2018-2023
4.3.2 By Type - Global Acute Myeloid Leukemia Drugs Sales, 2024-2029
4.3.3 By Type - Global Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Acute Myeloid Leukemia Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Myeloid Leukemia Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Acute Myeloid Leukemia Drugs Revenue & Forecasts
5.2.1 By Application - Global Acute Myeloid Leukemia Drugs Revenue, 2018-2023
5.2.2 By Application - Global Acute Myeloid Leukemia Drugs Revenue, 2024-2029
5.2.3 By Application - Global Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Acute Myeloid Leukemia Drugs Sales & Forecasts
5.3.1 By Application - Global Acute Myeloid Leukemia Drugs Sales, 2018-2023
5.3.2 By Application - Global Acute Myeloid Leukemia Drugs Sales, 2024-2029
5.3.3 By Application - Global Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Acute Myeloid Leukemia Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Acute Myeloid Leukemia Drugs Market Size, 2022 & 2029
6.2 By Region - Global Acute Myeloid Leukemia Drugs Revenue & Forecasts
6.2.1 By Region - Global Acute Myeloid Leukemia Drugs Revenue, 2018-2023
6.2.2 By Region - Global Acute Myeloid Leukemia Drugs Revenue, 2024-2029
6.2.3 By Region - Global Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Acute Myeloid Leukemia Drugs Sales & Forecasts
6.3.1 By Region - Global Acute Myeloid Leukemia Drugs Sales, 2018-2023
6.3.2 By Region - Global Acute Myeloid Leukemia Drugs Sales, 2024-2029
6.3.3 By Region - Global Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Acute Myeloid Leukemia Drugs Revenue, 2018-2029
6.4.2 By Country - North America Acute Myeloid Leukemia Drugs Sales, 2018-2029
6.4.3 US Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.4.4 Canada Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.4.5 Mexico Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Acute Myeloid Leukemia Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Acute Myeloid Leukemia Drugs Sales, 2018-2029
6.5.3 Germany Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.5.4 France Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.5.5 U.K. Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.5.6 Italy Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.5.7 Russia Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.5.9 Benelux Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Acute Myeloid Leukemia Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Acute Myeloid Leukemia Drugs Sales, 2018-2029
6.6.3 China Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.6.4 Japan Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.6.5 South Korea Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.6.7 India Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Acute Myeloid Leukemia Drugs Revenue, 2018-2029
6.7.2 By Country - South America Acute Myeloid Leukemia Drugs Sales, 2018-2029
6.7.3 Brazil Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.7.4 Argentina Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Sales, 2018-2029
6.8.3 Turkey Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.8.4 Israel Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Acute Myeloid Leukemia Drugs Market Size, 2018-2029
6.8.6 UAE Acute Myeloid Leukemia Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ambit Biosciences Corporation
7.1.1 Ambit Biosciences Corporation Company Summary
7.1.2 Ambit Biosciences Corporation Business Overview
7.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Major Product Offerings
7.1.4 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Ambit Biosciences Corporation Key News & Latest Developments
7.2 Celgene Corporation
7.2.1 Celgene Corporation Company Summary
7.2.2 Celgene Corporation Business Overview
7.2.3 Celgene Corporation Acute Myeloid Leukemia Drugs Major Product Offerings
7.2.4 Celgene Corporation Acute Myeloid Leukemia Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Celgene Corporation Key News & Latest Developments
7.3 Cephalon
7.3.1 Cephalon Company Summary
7.3.2 Cephalon Business Overview
7.3.3 Cephalon Acute Myeloid Leukemia Drugs Major Product Offerings
7.3.4 Cephalon Acute Myeloid Leukemia Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Cephalon Key News & Latest Developments
7.4 Clavis Pharma
7.4.1 Clavis Pharma Company Summary
7.4.2 Clavis Pharma Business Overview
7.4.3 Clavis Pharma Acute Myeloid Leukemia Drugs Major Product Offerings
7.4.4 Clavis Pharma Acute Myeloid Leukemia Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Clavis Pharma Key News & Latest Developments
7.5 Eisai
7.5.1 Eisai Company Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Acute Myeloid Leukemia Drugs Major Product Offerings
7.5.4 Eisai Acute Myeloid Leukemia Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Eisai Key News & Latest Developments
7.6 Genzyme Corporation
7.6.1 Genzyme Corporation Company Summary
7.6.2 Genzyme Corporation Business Overview
7.6.3 Genzyme Corporation Acute Myeloid Leukemia Drugs Major Product Offerings
7.6.4 Genzyme Corporation Acute Myeloid Leukemia Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Genzyme Corporation Key News & Latest Developments
7.7 Sunesis Pharmaceuticals
7.7.1 Sunesis Pharmaceuticals Company Summary
7.7.2 Sunesis Pharmaceuticals Business Overview
7.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Major Product Offerings
7.7.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Sunesis Pharmaceuticals Key News & Latest Developments
8 Global Acute Myeloid Leukemia Drugs Production Capacity, Analysis
8.1 Global Acute Myeloid Leukemia Drugs Production Capacity, 2018-2029
8.2 Acute Myeloid Leukemia Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Acute Myeloid Leukemia Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Acute Myeloid Leukemia Drugs Supply Chain Analysis
10.1 Acute Myeloid Leukemia Drugs Industry Value Chain
10.2 Acute Myeloid Leukemia Drugs Upstream Market
10.3 Acute Myeloid Leukemia Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Acute Myeloid Leukemia Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Acute Myeloid Leukemia Drugs in Global Market
Table 2. Top Acute Myeloid Leukemia Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Acute Myeloid Leukemia Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Acute Myeloid Leukemia Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Acute Myeloid Leukemia Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Acute Myeloid Leukemia Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Acute Myeloid Leukemia Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Acute Myeloid Leukemia Drugs Product Type
Table 9. List of Global Tier 1 Acute Myeloid Leukemia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Acute Myeloid Leukemia Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Acute Myeloid Leukemia Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Acute Myeloid Leukemia Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Acute Myeloid Leukemia Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Acute Myeloid Leukemia Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Acute Myeloid Leukemia Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Acute Myeloid Leukemia Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Acute Myeloid Leukemia Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Acute Myeloid Leukemia Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Acute Myeloid Leukemia Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Acute Myeloid Leukemia Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Acute Myeloid Leukemia Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Acute Myeloid Leukemia Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Acute Myeloid Leukemia Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Acute Myeloid Leukemia Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Acute Myeloid Leukemia Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Acute Myeloid Leukemia Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Acute Myeloid Leukemia Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Acute Myeloid Leukemia Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Acute Myeloid Leukemia Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Sales, (K Units), 2024-2029
Table 46. Ambit Biosciences Corporation Company Summary
Table 47. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product Offerings
Table 48. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Ambit Biosciences Corporation Key News & Latest Developments
Table 50. Celgene Corporation Company Summary
Table 51. Celgene Corporation Acute Myeloid Leukemia Drugs Product Offerings
Table 52. Celgene Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Celgene Corporation Key News & Latest Developments
Table 54. Cephalon Company Summary
Table 55. Cephalon Acute Myeloid Leukemia Drugs Product Offerings
Table 56. Cephalon Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Cephalon Key News & Latest Developments
Table 58. Clavis Pharma Company Summary
Table 59. Clavis Pharma Acute Myeloid Leukemia Drugs Product Offerings
Table 60. Clavis Pharma Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Clavis Pharma Key News & Latest Developments
Table 62. Eisai Company Summary
Table 63. Eisai Acute Myeloid Leukemia Drugs Product Offerings
Table 64. Eisai Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Eisai Key News & Latest Developments
Table 66. Genzyme Corporation Company Summary
Table 67. Genzyme Corporation Acute Myeloid Leukemia Drugs Product Offerings
Table 68. Genzyme Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Genzyme Corporation Key News & Latest Developments
Table 70. Sunesis Pharmaceuticals Company Summary
Table 71. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product Offerings
Table 72. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Sunesis Pharmaceuticals Key News & Latest Developments
Table 74. Acute Myeloid Leukemia Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Acute Myeloid Leukemia Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Acute Myeloid Leukemia Drugs Production by Region, 2018-2023 (K Units)
Table 77. Global Acute Myeloid Leukemia Drugs Production by Region, 2024-2029 (K Units)
Table 78. Acute Myeloid Leukemia Drugs Market Opportunities & Trends in Global Market
Table 79. Acute Myeloid Leukemia Drugs Market Drivers in Global Market
Table 80. Acute Myeloid Leukemia Drugs Market Restraints in Global Market
Table 81. Acute Myeloid Leukemia Drugs Raw Materials
Table 82. Acute Myeloid Leukemia Drugs Raw Materials Suppliers in Global Market
Table 83. Typical Acute Myeloid Leukemia Drugs Downstream
Table 84. Acute Myeloid Leukemia Drugs Downstream Clients in Global Market
Table 85. Acute Myeloid Leukemia Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Acute Myeloid Leukemia Drugs Segment by Type in 2022
Figure 2. Acute Myeloid Leukemia Drugs Segment by Application in 2022
Figure 3. Global Acute Myeloid Leukemia Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Myeloid Leukemia Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acute Myeloid Leukemia Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Acute Myeloid Leukemia Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia Drugs Revenue in 2022
Figure 9. By Type - Global Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Acute Myeloid Leukemia Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Acute Myeloid Leukemia Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Acute Myeloid Leukemia Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 23. US Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 28. Germany Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 37. China Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Acute Myeloid Leukemia Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Acute Myeloid Leukemia Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Acute Myeloid Leukemia Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Acute Myeloid Leukemia Drugs by Region, 2022 VS 2029
Figure 54. Acute Myeloid Leukemia Drugs Industry Value Chain
Figure 55. Marketing Channels
